Acute kidney injury in patients using amikacin in an era of carbapenem-resistant bacteria
- 8 July 2016
- journal article
- letter
- Published by Taylor & Francis in Infectious Diseases
- Vol. 48 (11-12) , 869-871
Abstract
Sir,We read with interest the report in the present journal by Papadimitriou-Olivgeris et al. on predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infectio...Keywords
This publication has 8 references indexed in Scilit:
- Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin BAntimicrobial Agents and Chemotherapy, 2016
- Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomesInternational Journal of Antimicrobial Agents, 2015
- Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unitScandinavian Journal of Infectious Diseases, 2014
- Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodiumInternational Journal of Antimicrobial Agents, 2014
- Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admissionJournal of Antimicrobial Chemotherapy, 2012
- Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009Eurosurveillance, 2010
- Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national expertsEurosurveillance, 2010
- A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patientsNephrology Dialysis Transplantation, 2008